Viewing data from:

MEFLOQUINE HYDROCHLORIDE

NDA

MEFLOQUINE HYDROCHLORIDE | N019578 | UNITED STATES ARMY WALTER REED ARMY INSTITUTE RESEARCH

1 strength0 unique patents0 unique exclusivities

PTAB Proceedings

No IPR/PGR/CBM challenges found at the Patent Trial and Appeal Board

Patent Reexaminations

No ex parte or inter partes reexamination proceedings found at USPTO

Hatch-Waxman Litigation

No ANDA patent litigation cases (NOS 835) matched from PACER

Citizen Petitions

No FDA citizen petitions matched from Regulations.gov

Clinical Trials

No clinical trials found on ClinicalTrials.gov for this drug

API Supply Chain3 active DMFs3 inactive

3 active API suppliers hold Drug Master Files for this ingredient.

PORTON PHARMA SOLUTIONS LTDMEFLOQUINE HYDROCHLORIDE

DMF 154132001

OLON SPAMEFLOQUINE HYDROCHLORIDE

DMF 156872001

SIEGFRIED EVIONNAZ SAMEFLOQUINE HYDROCHLORIDE

DMF 161272002

KNOLL AGInactiveMEFLOQUINE HYDROCHLORIDE

DMF 75491988

EMCURE PHARMACEUTICALS LTDInactiveMEFLOQUINE HYDROCHLORIDE USP

DMF 221382008

SHANGHAI DESANO CHEMICAL PHARMACEUTICAL CO LTDInactiveMEFLOQUINE HYDROCHLORIDE

DMF 268832013

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (1)

#001 — 250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

0 patents0 exclusivities▴

TABLET;ORAL | Approved: May 2, 1989

No patent or exclusivity listings for this strength.